• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重发热伴血小板减少综合征患者的临床进展和死亡风险因素。

Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients.

机构信息

Jinan Infectious Disease Hospital, Shandong University, Shandong Province, China.

出版信息

J Infect Dis. 2012 Oct 1;206(7):1095-102. doi: 10.1093/infdis/jis472. Epub 2012 Jul 30.

DOI:10.1093/infdis/jis472
PMID:22850122
Abstract

BACKGROUND

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by the SFTS virus (SFTSV) with an average fatality rate of 12%. The clinical factors for death in SFTS patients remain unclear.

METHODS

Clinical features and laboratory parameters were dynamically collected for 11 fatal and 48 non-fatal SFTS cases. Univariate logistic regression was used to evaluate the risk factors associated with death.

RESULTS

Dynamic tracking of laboratory parameters revealed that during the initial fever stage, the viral load was comparable for the patients who survived as well as the ones that died. Then in the second stage when multi-organ dysfunction occurred, from 7-13 days after disease onset, the viral load decreased in survivors but it remained high in the patients that died. The key risk factors that contributed to patient death were elevated serum aspartate aminotransferase, lactate dehydrogenase, creatine kinase, and creatine kinase fraction, as well as the appearance of CNS (central nervous system) symptoms, hemorrhagic manifestation, disseminated intravascular coagulation, and multi-organ failure. All clinical markers reverted to normal in the convalescent stage for SFTS patients who survived.

CONCLUSIONS

We identified a period of 7-13 days after the onset of illness as the critical stage in SFTS progression. A sustained serum viral load may indicate that disease conditions will worsen and lead to death.

摘要

背景

严重发热伴血小板减少综合征(SFTS)是一种由 SFTS 病毒(SFTSV)引起的新发传染病,平均病死率为 12%。SFTS 患者死亡的临床因素仍不清楚。

方法

对 11 例死亡和 48 例非死亡 SFTS 病例进行了临床特征和实验室参数的动态采集。采用单因素逻辑回归分析评估与死亡相关的危险因素。

结果

实验室参数的动态跟踪显示,在发热初期,存活患者和死亡患者的病毒载量相当。然后在第二阶段,即发病后 7-13 天,多器官功能障碍发生时,存活患者的病毒载量下降,但死亡患者的病毒载量仍然很高。导致患者死亡的关键危险因素是血清天门冬氨酸转氨酶、乳酸脱氢酶、肌酸激酶和肌酸激酶同工酶升高,以及出现中枢神经系统(CNS)症状、出血表现、弥散性血管内凝血和多器官衰竭。所有临床标志物在 SFTS 存活患者的恢复期均恢复正常。

结论

我们确定了发病后 7-13 天是 SFTS 进展的关键阶段。持续的血清病毒载量可能表明病情会恶化并导致死亡。

相似文献

1
Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients.严重发热伴血小板减少综合征患者的临床进展和死亡风险因素。
J Infect Dis. 2012 Oct 1;206(7):1095-102. doi: 10.1093/infdis/jis472. Epub 2012 Jul 30.
2
Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome.宿主细胞因子风暴与发热伴血小板减少综合征的疾病严重程度相关。
J Infect Dis. 2012 Oct 1;206(7):1085-94. doi: 10.1093/infdis/jis452. Epub 2012 Aug 17.
3
Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China.中国严重发热伴血小板减少综合征患者的临床进展和死亡预测因素。
J Clin Virol. 2014 Jan;59(1):12-7. doi: 10.1016/j.jcv.2013.10.024. Epub 2013 Oct 31.
4
Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis.中国发热伴血小板减少综合征的流行病学及临床特征:一项整合数据分析
Epidemiol Infect. 2016 Apr;144(6):1345-54. doi: 10.1017/S0950268815002678. Epub 2015 Nov 6.
5
Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection.发热伴血小板减少综合征病毒感染急性期临床和免疫学标志物的预后价值。
Clin Microbiol Infect. 2014 Nov;20(11):O870-8. doi: 10.1111/1469-0691.12636. Epub 2014 May 15.
6
Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis.发热伴血小板减少综合征布尼亚病毒相关脑炎。
J Infect. 2015 Jan;70(1):52-9. doi: 10.1016/j.jinf.2014.08.001. Epub 2014 Aug 16.
7
Nucleocapsid protein-specific IgM antibody responses in the disease progression of severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征疾病进展过程中核衣壳蛋白特异性 IgM 抗体反应。
Ticks Tick Borne Dis. 2019 Apr;10(3):639-646. doi: 10.1016/j.ttbdis.2019.02.003. Epub 2019 Feb 7.
8
A cluster of person-to-person transmission cases caused by SFTS virus in Penglai, China.中国蓬莱由发热伴血小板减少综合征病毒引起的一组人际传播病例。
Clin Microbiol Infect. 2015 Mar;21(3):274-9. doi: 10.1016/j.cmi.2014.10.006. Epub 2014 Oct 29.
9
Age is a critical risk factor for severe fever with thrombocytopenia syndrome.年龄是发热伴血小板减少综合征的一个关键风险因素。
PLoS One. 2014 Nov 4;9(11):e111736. doi: 10.1371/journal.pone.0111736. eCollection 2014.
10
Dynamic changes of laboratory parameters and peripheral blood lymphocyte subsets in severe fever with thrombocytopenia syndrome patients.发热伴血小板减少综合征患者实验室参数和外周血淋巴细胞亚群的动态变化。
Int J Infect Dis. 2017 May;58:45-51. doi: 10.1016/j.ijid.2017.02.017. Epub 2017 Feb 27.

引用本文的文献

1
Long-term clinical sequelae in severe fever with thrombocytopenia syndrome: A longitudinal cohort study.严重发热伴血小板减少综合征的长期临床后遗症:一项纵向队列研究。
PLoS Negl Trop Dis. 2025 Aug 12;19(8):e0013276. doi: 10.1371/journal.pntd.0013276. eCollection 2025 Aug.
2
Alarming implications: severe fever with thrombocytopenia syndrome and its biological vectors in the context of climate change.警示意义:气候变化背景下的严重发热伴血小板减少综合征及其生物媒介
Front Microbiol. 2025 Jul 25;16:1544427. doi: 10.3389/fmicb.2025.1544427. eCollection 2025.
3
Latest advances and prospects in the pathogenesis, animal models, and vaccine research of severe fever with thrombocytopenia syndrome virus.
发热伴血小板减少综合征病毒发病机制、动物模型及疫苗研究的最新进展与展望
Front Immunol. 2025 Jun 26;16:1624290. doi: 10.3389/fimmu.2025.1624290. eCollection 2025.
4
The public health threat of emerging phenuiviruses.新出现的白蛉病毒的公共卫生威胁。
One Health. 2025 May 6;20:101055. doi: 10.1016/j.onehlt.2025.101055. eCollection 2025 Jun.
5
: A review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention.流行病学、临床特征、病理生理学、治疗与预防综述
Virulence. 2025 Dec;16(1):2520343. doi: 10.1080/21505594.2025.2520343. Epub 2025 Jun 17.
6
Respiratory transmission potential of severe fever with thrombocytopenia syndrome bunyavirus: evidence from intranasal exposure in a humanized mouse model.发热伴血小板减少综合征布尼亚病毒的呼吸道传播潜力:来自人源化小鼠模型鼻内暴露的证据
Emerg Microbes Infect. 2025 Dec;14(1):2511134. doi: 10.1080/22221751.2025.2511134. Epub 2025 Jun 19.
7
A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study.用于严重发热伴血小板减少综合征患者死亡率预测的机器学习模型:一项前瞻性、多中心队列研究。
Emerg Microbes Infect. 2025 Dec;14(1):2498572. doi: 10.1080/22221751.2025.2498572. Epub 2025 Jun 19.
8
Metabolic Profiling Reveals Potential Prognostic Biomarkers for SFTS: Insights into Disease Severity and Clinical Outcomes.代谢谱分析揭示了严重发热伴血小板减少综合征潜在的预后生物标志物:对疾病严重程度和临床结局的见解。
Metabolites. 2025 Mar 27;15(4):228. doi: 10.3390/metabo15040228.
9
Time-Varying Effects of Glucocorticoid Treatment in Critically III Patients with Severe Fever with Thrombocytopenia Syndrome: An Inverse Probability of Treatment Weighting Analysis.糖皮质激素治疗对重症发热伴血小板减少综合征重症患者的时变效应:一项治疗权重逆概率分析
J Inflamm Res. 2025 Apr 18;18:5311-5327. doi: 10.2147/JIR.S505421. eCollection 2025.
10
Establishment and application of a grading diagnostic model for early detection of severe fever with thrombocytopenia syndrome.一种用于早期诊断发热伴血小板减少综合征的分级诊断模型的建立与应用
Ann Med. 2025 Dec;57(1):2493307. doi: 10.1080/07853890.2025.2493307. Epub 2025 Apr 20.